Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 35 studies | 43% ± 19% | |
| astrocyte | 16 studies | 45% ± 21% | |
| endothelial cell of lymphatic vessel | 14 studies | 53% ± 24% | |
| ciliated cell | 14 studies | 36% ± 15% | |
| microglial cell | 13 studies | 45% ± 15% | |
| vein endothelial cell | 13 studies | 43% ± 29% | |
| glutamatergic neuron | 11 studies | 41% ± 22% | |
| macrophage | 11 studies | 30% ± 14% | |
| oligodendrocyte | 11 studies | 34% ± 13% | |
| oligodendrocyte precursor cell | 10 studies | 36% ± 14% | |
| endothelial cell of vascular tree | 10 studies | 34% ± 22% | |
| GABAergic neuron | 9 studies | 47% ± 21% | |
| epithelial cell | 9 studies | 34% ± 16% | |
| basal cell | 9 studies | 35% ± 16% | |
| club cell | 8 studies | 35% ± 17% | |
| capillary endothelial cell | 8 studies | 32% ± 18% | |
| adipocyte | 8 studies | 34% ± 10% | |
| endothelial cell of artery | 8 studies | 38% ± 23% | |
| pericyte | 7 studies | 25% ± 13% | |
| fibroblast | 7 studies | 27% ± 7% | |
| respiratory goblet cell | 6 studies | 47% ± 23% | |
| interneuron | 6 studies | 53% ± 19% | |
| retina horizontal cell | 6 studies | 48% ± 25% | |
| type II pneumocyte | 6 studies | 47% ± 15% | |
| smooth muscle cell | 5 studies | 35% ± 20% | |
| neuron | 5 studies | 50% ± 22% | |
| dendritic cell | 5 studies | 19% ± 0% | |
| lymphocyte | 5 studies | 26% ± 11% | |
| monocyte | 5 studies | 31% ± 6% | |
| type I pneumocyte | 5 studies | 29% ± 9% | |
| cholangiocyte | 4 studies | 58% ± 21% | |
| hepatocyte | 4 studies | 72% ± 24% | |
| granule cell | 4 studies | 28% ± 3% | |
| retinal bipolar neuron | 4 studies | 28% ± 12% | |
| cardiac muscle cell | 4 studies | 22% ± 4% | |
| retinal ganglion cell | 4 studies | 42% ± 23% | |
| T cell | 4 studies | 28% ± 7% | |
| ionocyte | 3 studies | 35% ± 8% | |
| secretory cell | 3 studies | 25% ± 1% | |
| endothelial cell of sinusoid | 3 studies | 43% ± 11% | |
| GABAergic interneuron | 3 studies | 45% ± 18% | |
| CD4-positive, alpha-beta T cell | 3 studies | 23% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| endocardial cell | 3 studies | 50% ± 24% | |
| mesothelial cell | 3 studies | 33% ± 11% | |
| GABAergic amacrine cell | 3 studies | 41% ± 13% | |
| Mueller cell | 3 studies | 34% ± 7% | |
| ON-bipolar cell | 3 studies | 46% ± 20% | |
| amacrine cell | 3 studies | 34% ± 8% | |
| glycinergic amacrine cell | 3 studies | 29% ± 9% | |
| retinal rod cell | 3 studies | 21% ± 4% | |
| myeloid cell | 3 studies | 24% ± 6% | |
| abnormal cell | 3 studies | 34% ± 22% | |
| ependymal cell | 3 studies | 30% ± 13% | |
| alveolar macrophage | 3 studies | 25% ± 8% | |
| natural killer cell | 3 studies | 23% ± 4% | |
| transit amplifying cell | 3 studies | 31% ± 18% | |
| brush cell | 3 studies | 31% ± 10% | |
| mast cell | 3 studies | 25% ± 5% | |
| mucus secreting cell | 3 studies | 54% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 5375.02 | 245 / 245 | 100% | 53.92 | 500 / 502 |
| stomach | 100% | 5219.03 | 359 / 359 | 99% | 36.52 | 283 / 286 |
| intestine | 100% | 3567.90 | 964 / 966 | 98% | 30.69 | 515 / 527 |
| pancreas | 100% | 3683.94 | 327 / 328 | 98% | 21.85 | 174 / 178 |
| thymus | 100% | 9045.97 | 653 / 653 | 96% | 24.87 | 579 / 605 |
| lung | 100% | 9665.32 | 578 / 578 | 94% | 21.89 | 1082 / 1155 |
| bladder | 100% | 3921.33 | 21 / 21 | 92% | 26.82 | 466 / 504 |
| esophagus | 100% | 2933.84 | 1444 / 1445 | 92% | 28.19 | 169 / 183 |
| kidney | 100% | 3297.78 | 89 / 89 | 91% | 15.76 | 822 / 901 |
| liver | 100% | 5531.50 | 226 / 226 | 91% | 16.42 | 370 / 406 |
| breast | 100% | 5986.37 | 459 / 459 | 89% | 17.55 | 992 / 1118 |
| ovary | 99% | 2730.63 | 179 / 180 | 86% | 12.01 | 368 / 430 |
| uterus | 100% | 3859.32 | 170 / 170 | 83% | 13.74 | 381 / 459 |
| brain | 80% | 1467.17 | 2124 / 2642 | 84% | 8.25 | 593 / 705 |
| skin | 86% | 4487.95 | 1562 / 1809 | 67% | 6.08 | 316 / 472 |
| adrenal gland | 99% | 2355.50 | 255 / 258 | 39% | 3.12 | 89 / 230 |
| adipose | 100% | 6100.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 6534.01 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2993.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.49 | 1 / 1 |
| peripheral blood | 95% | 5258.95 | 882 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 95% | 1961.46 | 1263 / 1335 | 0% | 0 | 0 / 0 |
| heart | 93% | 1843.66 | 804 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 12.81 | 37 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 3.80 | 14 / 29 |
| eye | 0% | 0 | 0 / 0 | 26% | 1.82 | 21 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0090630 | Biological process | activation of GTPase activity |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | RALGAPA2 |
| Protein name | Ral GTPase activating protein catalytic subunit alpha 2 Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220) |
| Synonyms | C20orf74 KIAA1272 |
| Description | FUNCTION: Catalytic subunit of the heterodimeric RalGAP2 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB. . |
| Accessions | ENST00000202677.12 [Q2PPJ7-1] ENST00000430436.5 A0A3B3IS41 H7BZA8 ENST00000427175.2 Q2PPJ7 H7C1F9 ENST00000495793.2 |